Results 91 to 100 of about 405 (144)

Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]

Front Microbiol
Frontiers Production Office.
europepmc   +1 more source

Classification and applicability of new beta-lactamase inhibitors. [PDF]

Rev Esp Quimioter
Cercenado E, Candel FJ.
europepmc   +1 more source

Carbapenem resistance in a <i>Klebsiella quasipneumoniae</i> isolate resulting from production of CTX-M-33 and OmpK36 porin deficiency. [PDF]

Antimicrob Agents Chemother
Findlay J, Nordmann P, Jayol A, Seth-Smith HMB, Egli A, Poirel L.   +5 more
europepmc   +1 more source

Impact of Acquired Broad Spectrum β-Lactamases on Susceptibility to Novel Combinations Made of β-Lactams (Aztreonam, Cefepime, Meropenem, and Imipenem) and Novel β-Lactamase Inhibitors in Escherichia coli and Pseudomonas aeruginosa. [PDF]

Antimicrob Agents Chemother, 2023
Le Terrier C, Nordmann P, Freret C, Seigneur M, Poirel L.   +4 more
europepmc   +1 more source

New Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria. [PDF]

Antibiotics (Basel)
Machado E, Sousa JC.
europepmc   +1 more source

Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]

Front Microbiol
Sartori M, Toppo S, Lavezzo E.
europepmc   +1 more source

How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach. [PDF]

Curr Opin Infect Dis
Tiseo G, Galfo V, Falcone M.
europepmc   +1 more source

Mechanism, Dynamics and Inhibition of Class A β-Lactamases through Computation and Experiment [PDF]

Beer, Michael
core  

Insights into antibiotic inactivation by β-lactamases from multiscale simulations [PDF]

, 2021
Hirvonen, Viivi H A
core  

Introduction to XIV updating course of antimicrobials and infectious diseases. [PDF]

Rev Esp Quimioter
Candel FJ, Matesanz M.
europepmc   +1 more source